How we manage hyperferritinemic sepsis-related multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis histiocytosis

Pediatric Critical Care Medicine

Volumn 16, Issue 6, 2015, Pages 598-600

  Carcillo, Joseph A ^a   Simon, Dennis W ^a   Podd, Bradley S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

hemophagocytic lymphohistiocytosis; hyperferritinemia; macrophage activation syndrome; sepsis

Indexed keywords

FERRITIN; INFLAMMASOME;

APOPTOSIS; BONE MARROW TRANSPLANTATION; CINCA SYNDROME; CYTOPENIA; EDITORIAL; FERRITIN BLOOD LEVEL; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE ACTIVATION SYNDROME; MORTALITY; MULTIPLE ORGAN FAILURE; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SEPSIS RELATED MULTIPLE ORGAN DYSFUNCTION SYNDROME; SEPTIC SHOCK; FEMALE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE;

FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE;

EID: 84937685421     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000000460     Document Type: Editorial

References (19)

1. Ruddell RG, Hoang-Le D, Barwood JM, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/.nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology. 2009; 49: 887-900
2. Li R, Luo C, Mines M, et al. Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain. J Biol Chem. 2006; 281: 37616-37627
3. Broxmeyer HE, Cooper S, Levi S, et al. Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: A link between ferritin ferroxidase activity and biological function. Proc Natl Acad Sci U S A. 1991; 88: 770-774
4. Garcia PC, Longhi F, Branco RG, et al. Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr. 2007; 96: 1829-1831
5. Bennett TD, Hayward KN, Farris RW, et al. Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients. Pediatr Crit Care Med. 2011; 12: e233-e236
6. Castillo L, Carcillo J: Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009; 10: 387-392
7. Stéphan JL, Koné-Paut I, Galambrun C, et al. Reactive haemophagocytic syndrome in children with inflammatory disorders A retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40: 1285-1292
8. Kaufman KM, Linghu B, Szustakowski JD, et al. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2014; 66: 3486-3495
9. Minoia F, Davì S, Horne A, et al. Pediatric Rheumatology International Trials Organization; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society: Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014; 66: 3160-3169
10. Trottestam H, Horne A, Aricò M, et al. Histiocyte Society: Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: Long-Term results of the HLH-94 treatment protocol. Blood. 2011; 118: 4577-4584
11. Behrens EM, Canna SW, Slade K, et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest. 2011; 121: 2264-2277
12. Tsujimoto H, Ono S, Matsumoto A, et al A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed tolllike receptor-9 on liver NKT cells. J Hepatol. 2006; 45: 836-843
13. Petrasek J, Dolganiuc A, Csak T, et al. Type I interferons protect from Toll-like receptor 9-Associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology. 2011; 140: 697-708.e4
14. Shakoory B, Carcillo J, Zhao H, et al. IL-1 receptor antagonism improves mortality in severe sepsis subset with hemophagocytic syndrome. Crit Care Med. 2013; 41: A1105
15. Rajasekaran S, Kruse K, Kovey K, et al. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/.macrophage activating syndrome in critically ill children. Pediatr Crit Care Med. 2014; 15: 401-408
16. Simon DW, Aneja R, Carcillo JA, et al. Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-Associated sepsis/.multiple organ dysfunction syndrome/macrophage activation syndrome/.secondary hemophagocytic lymphohistiocytosis syndrome. Pediatr Crit Care Med. 2014; 15: 486-488
17. Demirkol D, Yildizdas D, Bayrakci B, et al. Turkish Secondary HLH/.MAS Critical Care Study Group: Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/.multiple organ dysfunction syndrome/macrophage activation syndrome: What is the treatment? Crit Care. 2012; 16: R52
18. Halstead ES, Carcillo JA, Schilling B, et al. Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patients. Pediatr Res. 2013; 74: 427-432
19. Kaya Z, Bay A, Albayrak M, et al. Prognostic Factors and Long-Term Outcome in 52 Turkish Children With Hemophagocytic Lymphohistiocytosis. Pediatr Crit Care Med. 2015; 16: e165-e173